Companies  » Health Care
 

Lupin gains on inclusion in Sensex from June 22

At 0957 hours, the stock was up 2% at Rs 1,768 on the BSE.

Natco Pharma Q4 net profit up 126% at Rs 54 cr

22 May 2015

Total income up 5.28% to Rs 204 crore, helped by revenue growth from bulk chemicals and formulations

Strides Arcolab standalone Q4 net swings into black

22 May 2015

Bengaluru-based drug maker Strides Arcolab today reported a standalone net profit of Rs 69.66 crore for the quarter-ended March 31, 2015. The ...

Strides Arcolab Q4 net profit at Rs 69.66 cr

22 May 2015

The company had posted a net loss of Rs 48.26 crore for the corresponding period of the previous fiscal

Suven Life Sciences gets patents for neurodegenerative drug

22 May 2015

Biopharmaceutical firm Suven Life Sciences today said it has been granted one patent each by Mexico and Singapore for a drug used in the ...

Suven Life Sciences gains on receiving patents

22 May 2015

The company has received one product patent from Mexico and one from Singapore for new chemical entities to treat neuro-degenerative diseases.

Strides Arcolab to acquire Aspen's Australia assets

22 May 2015

Acquisition, valued at Rs 1,900 crore, will help Strides rebuild its Australia business

Strides Arcolab does kangaroo jump

21 May 2015

Australian acquisition expected to be EPS-accretive from the start; earlier Shasun merger brightens outlook for US market; analysts positive on ...

Strides Arcolab surges on plans to buy Aspen's generic pharma business

21 May 2015

The stock moved higher by 7% to Rs 1,171 after the company inked an agreement to acquire the generic pharmaceutical business in Australia and ...

Strides Arcolab to buy some Australia drug assets from Aspen Pharmacare

21 May 2015

Drugmaker Strides Arcolab Ltd said on Thursday it has agreed to buy a generic drugs business in Australia from South Africa's Aspen Pharmacare ...

Glenmark gets tentative USFDA nod to sell Rufinamide

21 May 2015

Glenmark Pharmaceuticals today said it has been granted tentative approval by the US health regulator to sell Rufinamide, which is used to treat ...

Aarti Drugs dips on weak Q4 results

21 May 2015

The stock dipped 7% to Rs 688 after reporting a 14% year-on-year decline in net profit at Rs 18.86 crore in the March quarter.

Cadila Healthcare near deal to buy smaller rival Claris: report

21 May 2015

Cadila Healthcare Ltd, among India's top ten drugmakers, is in late-stage talks to buy smaller rival Claris Lifesciences Ltd for about 34 ...

Claris Lifesciences gains on injectible biz sale buzz

21 May 2015

At 0958 hours, the stock was up 11% to Rs 312 on the BSE, accompanied by over 10-fold jump in trading volumes.

More regional companies exit national bourses

20 May 2015

Stocks of companies under 'permitted to trade' category to be discontinued

Sequent Scientific extends decline after fixing QIP price

20 May 2015

The stock dipped 4% to Rs 600, extending its previous day's 3.5% fall after the company fixed a floor price at Rs 562.56 for the QIP issue.

Glenmark Pharma gains on RBI nod to raise FII limit to 49%

20 May 2015

The stock was up 3% at Rs 928 on the NSE in early morning trade.

Cadila: Strong Q4, encouraging outlook

19 May 2015

Analysts expect the company's US growth to remain strong and domestic demand to bounce back leading to an up to 18% upside in the stock

Alembic Pharma hits record high on heavy volumes

19 May 2015

The stock has rallied 5% to Rs 536 after a huge block deal executed on the BSE.

Quick Links


Back to Top